Global Hyperhidrosis Treatment Market
Hyperhidrosis Treatment Market

Report ID: SQSG35J2014

sales@skyquestt.com
USA +1 351-333-4748

Hyperhidrosis Treatment Market Size, Share, and Growth Analysis

Global Hyperhidrosis Treatment Market

Hyperhidrosis Treatment Market By Type (Axillary hyperhidrosis, Palmar hyperhidrosis), By Treatment (Topical treatment, Oral medication), By Age (Up to 50 years, Above 50 years), By End-user, By Region - Industry Forecast 2026-2033


Report ID: SQSG35J2014 | Region: Global | Published Date: January, 2025
Pages: 157 |Tables: 93 |Figures: 76

Format - word format excel data power point presentation

Hyperhidrosis Treatment Market Insights

Global Hyperhidrosis Treatment Market size was valued at USD 707.44 Million in 2024 and is poised to grow from USD 745.65 Million in 2025 to USD 1135.69 Million by 2033, growing at a CAGR of 5.4% during the forecast period (2026–2033).

For treating hyperhidrosis, antiperspirants and topical treatments are the first line of defense. Hyperhidrosis, however, still has no known permanent treatment. There has been a lot of activity in recent years regarding technological and product developments. Companies have been encouraged to invest in this industry by the patients' preference for novel approaches and the growing understanding of the treatment choices.

The prevalence of secondary hyperhidrosis disorders is on the rise, and market participants are increasing their spending in R&D, which are the main drivers of market growth for hyperhidrosis treatments. According to a study by Jared Brackenrich that was published in the National Library of Medicine in October 2021, this disorder is thought to be relatively common in the United States, with an estimated 3% prevalence. Hyperhidrosis can impede social, psychological, emotional, and vocational functioning. Therefore, it is projected that the growing prevalence of hyperhidrosis will increase demand for therapy and consequently accelerate market expansion.

Another aspect that may have an impact on market expansion is the promising therapy pipeline for hyperhidrosis, as well as the presence of advantageous reimbursement policies, rising rates of anxiety and depression, and increased public awareness of hyperhidrosis. As an example, Brickell Biotech Inc. released encouraging topline findings from the Phase 3 pivotal Cardigan I and Cardigan II studies in October 2021. These studies assessed the effectiveness of 15% sofpironium bromide gel as a once-daily topical formulation in people with primary axillary hyperhidrosis.

US Hyperhidrosis Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2026-2033

Global Market Size

USD 671.2 million

Largest Segment

Primary Focal

Fastest Growth

Primary Focal

Growth Rate

5.4% CAGR

Global Hyperhidrosis Treatment Market2022-2028 2026-2033 ($ Bn)
Country Share for North America Region- 2025 (%)

To get more insights on this market click here to Request a Free Sample Report

Hyperhidrosis Treatment Market Segments Analysis

Global Hyperhidrosis Treatment Market is segmented by Type, Treatment, Age, End-user and region. Based on Type, the market is segmented into Axillary hyperhidrosis, Palmar hyperhidrosis, Plantar hyperhidrosis and Other types. Based on Treatment, the market is segmented into Topical treatment, Oral medication, Botulinum toxin injections, Iontophoresis and Surgical treatment. Based on Age, the market is segmented into Up to 50 years and Above 50 years. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers, Dermatology clinics and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Hyperhidrosis Treatment Market Analysis by Type of Treatment

The botulinum toxin A is anticipated to command the largest share in the global market. The US Food and Drug Administration (FDA) approved BOTOX (onabotulinumtoxinA) in 2004 for the treatment of severe primary axillary hyperhidrosis (excessive sweating of the underarms). The sole license to register, sell, and commercialize a botulinum toxin in the US and Canada was obtained by Aquavit Holdings LLC, it was revealed in April 2021. The second largest market share is captured by surgical treatment. The lasers treatment is widely used surgical procedure for treatment.

Hyperhidrosis Treatment Market Analysis by Hyperhidrosis Type

Based on hyperhidrosis type, the secondary generalized segment is anticipated to register the highest growth during the forecast period. It is caused by any medical condition or due to side-effect of any medication. Growing prevalence of depression and anxiety globally is one of the key attributing factor for the growth of the segment.

Global Hyperhidrosis Treatment Market By Type 2025 (%)

To get detailed segments analysis, Request a Free Sample Report

Hyperhidrosis Treatment Market Regional Insights

North America is anticipated to dominate the global hyperhidrosis treatment market. Due to the high prevalence of various illnesses and existence of major market participants in the nation, the United States retains a sizable portion of the market. About 3% of Americans suffer from hyperhidrosis, which most frequently affects people between the ages of 20 and 60. Additionally, the growth of this market in the United States is anticipated to be fueled by rising research and development activities for hyperhidrosis treatment products in the country. This will result in higher acceptance of these products.

The second-largest market for treating hyperhidrosis is in Europe. Some of the elements influencing the expansion in the area are the increased government support for research & development, the rising number of players interested in the creation of innovative therapeutic techniques, and the rising awareness of the illness.

The hyperhidrosis treatment market is expected to develop at the quickest rate in Asia Pacific. The prevalence of illness has been rising in this region. The hyperhidrosis treatment market has expanded significantly due in large part to rising awareness of this illness.

Middle East and Africa has the smallest market because of poor healthcare infrastructure, little disease awareness, and low per capita disposable incomes in developing region.

Global Hyperhidrosis Treatment MarketBy Geography, 2026-2033
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Hyperhidrosis Treatment Market Dynamics

Hyperhidrosis Treatment Market Driver

  • Healthcare providers are researching radiofrequency microneedling-based hyperhidrosis treatments and the outcomes seen in hyperhidrosis patients. Stakeholders are attempting to determine whether fractional microneedle radiofrequency treatment has long-term benefits, particularly for patients with primary axillary hyperhidrosis. These studies were evaluated using the hyperhidrosis disease severity scale (HDSS), which revealed that patients improved dramatically after treatment.
  • Another hyperhidrosis treatment that is gaining popularity among patients is tap water iontophoresis, which involves passing an ionized substance through the skin using a direct electric current. Several clinical trials have revealed significant improvements in patients suffering from plantar and palmar hyperhidrosis. These positive results contributed to patients' improved quality of life and a significant decrease in sweat secretion rate.
  • The latest R&D activities associated with the market are gaining attraction globally. For instance,Brickell Biotech Inc. reported positive topline results from the Phase 3 pivotal Cardigan I and Cardigan II studies that evaluated sofpironium bromide gel, 15% as a once-daily topical formulation in patients having primary axillary hyperhidrosis. This boosts the market growth.

Hyperhidrosis Treatment Market Restraints

  • One of the major drawbacks of hyperhidrosis treatment, particularly Botulinum toxin injections, is its transient efficacy in patients who become less tolerant to the dosage as they become accustomed to it. Another issue affecting the hyperhidrosis treatment market is the financial burden and psychological distress that patients face because many medical insurance companies do not cover hyperhidrosis treatment.

Request Free Customization of this report to help us to meet your business objectives.

Hyperhidrosis Treatment Market Competitive Landscape

There are a significant number of participants in the hyperhidrosis treatment market, which is moderately consolidated. Currently, a small subset of the key firms control the majority of the market share. Business organisations are concentrating on organic growth techniques such product launches, product approvals, and others like patents and events. Acquisitions and partnerships & collaborations were two inorganic growth tactics that were observed in the market. The expansion of the companies' operations and clientele of market participants has been made possible by these initiatives. The growing demand for hyperhidrosis treatments in the global market is predicted to provide the market participants in the hyperhidrosis treatment sector with attractive growth prospects in the future. In addition, some major corporations are actively acquiring other businesses to strengthen their market positions globally (Sientra acquired Miramar).

Top Players in the Global Hyperhidrosis Treatment Market

  • AbbVie Inc. (US)
  • Avanor Healthcare Ltd. (UK) 
  • Brickell Biotech Inc. (US) 
  • Dermadry Laboratories Inc. (Canada) 
  • Dermavant Sciences Inc. (US) 
  • Hugel, Inc. (South Korea) 
  • Eirion Therapeutics, Inc. (US) 
  • Eli Lilly and Company (US) 
  • Intas Pharmaceuticals Ltd. (India) 
  • Kaken Pharmaceutical Co., Ltd. (Japan) 
  • Maruho Co., Ltd. (Japan) 
  • miraDry, Inc. (US) 
  • SweatBlock (US) 
  • Roivant Sciences Ltd. (Switzerland) 
  • Theravida, Inc. (US) 
  • Dr. August Wolff GmbH (Germany) 
  • Dr. Reddy's Laboratories Ltd. (India) 
  • GSK Plc (UK) 
  • Revance (US) 
  • NovaMedica (Russia)

Hyperhidrosis Treatment Market Recent Developments

  • In May 2022, Maruho launched Rapport Wipes in Japan, used for the treatment of primary axillary hyperhidrosis. It is the first prescription wipe preparation in the country.
  • In October 2022, Candesant Biomedical ("Candesant"), a clinical stage company focused on the development of non-invasive treatments for primary hyperhidrosis (excessive sweating), today announced the "SweatTech Initiative" to raise awareness of the significant impact of excessive sweating, educate on how treatments have evolved over the decades, and demonstrate the ongoing need for more modern treatments.
  • With patients who have primary axillary hyperhidrosis, August Wolff GmbH & Co. KG Arzneimittel is assessing the effectiveness and safety of topical administration of 1% glycopyrronium bromide (GPB) as well as the effectiveness and safety of this treatment over the long term. The phase 4 clinical trial began on November 2, 2021, after the phase 3 clinical trial was finished.
  • The Topical Aluminium Chloride vs. Onabotulinumtoxina Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs) study, which is being conducted by Centrale du Service de santA, just finished its phase 3 clinical trial. The phase 4 clinical trial is scheduled to begin soon.

Hyperhidrosis Treatment Key Market Trends

Hyperhidrosis Treatment Market SkyQuest Analysis

SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research

According to our analysis, hyperhidrosis treatment market is going to boom in the upcoming years because of increasing awareness and acceptance of hyperhidrosis treatment due to launch of new products and novel treatment options. The botulinum toxin A segment will be dominating the market during the forecast period as it is a safe and effective treatment for focal hyperhidrosis and it last longer than topical treatment and also does not require invasive surgical procedure.

Report Metric Details
Market size value in 2024 USD 707.44 Million
Market size value in 2033 USD 1135.69 Million
Growth Rate 5.4%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Million
Segments covered
  • Type
    • Axillary hyperhidrosis, Palmar hyperhidrosis, Plantar hyperhidrosis, Other types
  • Treatment
    • Topical treatment, Oral medication (Anticholinergics, Other oral medications), Botulinum toxin injections, Iontophoresis, Surgical treatment
  • Age
    • Up to 50 years, Above 50 years
  • End-user
    • Hospitals, Ambulatory surgical centers, Dermatology clinics, Other end-users
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • AbbVie Inc. (US)
  • Avanor Healthcare Ltd. (UK) 
  • Brickell Biotech Inc. (US) 
  • Dermadry Laboratories Inc. (Canada) 
  • Dermavant Sciences Inc. (US) 
  • Hugel, Inc. (South Korea) 
  • Eirion Therapeutics, Inc. (US) 
  • Eli Lilly and Company (US) 
  • Intas Pharmaceuticals Ltd. (India) 
  • Kaken Pharmaceutical Co., Ltd. (Japan) 
  • Maruho Co., Ltd. (Japan) 
  • miraDry, Inc. (US) 
  • SweatBlock (US) 
  • Roivant Sciences Ltd. (Switzerland) 
  • Theravida, Inc. (US) 
  • Dr. August Wolff GmbH (Germany) 
  • Dr. Reddy's Laboratories Ltd. (India) 
  • GSK Plc (UK) 
  • Revance (US) 
  • NovaMedica (Russia)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Hyperhidrosis Treatment Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Hyperhidrosis Treatment Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Hyperhidrosis Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Hyperhidrosis Treatment Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Hyperhidrosis Treatment Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Hyperhidrosis Treatment Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

Hyperhidrosis Treatment Market Report Snapshots

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Hyperhidrosis Treatment Market size was valued at USD 707.44 Million in 2024 and is poised to grow from USD 745.65 Million in 2025 to USD 1135.69 Million by 2033, growing at a CAGR of 5.4% during the forecast period (2026–2033).

There are a significant number of participants in the hyperhidrosis treatment market, which is moderately consolidated. Currently, a small subset of the key firms control the majority of the market share. Business organisations are concentrating on organic growth techniques such product launches, product approvals, and others like patents and events. Acquisitions and partnerships & collaborations were two inorganic growth tactics that were observed in the market. The expansion of the companies' operations and clientele of market participants has been made possible by these initiatives. The growing demand for hyperhidrosis treatments in the global market is predicted to provide the market participants in the hyperhidrosis treatment sector with attractive growth prospects in the future. In addition, some major corporations are actively acquiring other businesses to strengthen their market positions globally (Sientra acquired Miramar). 'AbbVie Inc. (US)', 'Avanor Healthcare Ltd. (UK) ', 'Brickell Biotech Inc. (US) ', 'Dermadry Laboratories Inc. (Canada) ', 'Dermavant Sciences Inc. (US) ', 'Hugel, Inc. (South Korea) ', 'Eirion Therapeutics, Inc. (US) ', 'Eli Lilly and Company (US) ', 'Intas Pharmaceuticals Ltd. (India) ', 'Kaken Pharmaceutical Co., Ltd. (Japan) ', 'Maruho Co., Ltd. (Japan) ', 'miraDry, Inc. (US) ', 'SweatBlock (US) ', 'Roivant Sciences Ltd. (Switzerland) ', 'Theravida, Inc. (US) ', 'Dr. August Wolff GmbH (Germany) ', 'Dr. Reddy's Laboratories Ltd. (India) ', 'GSK Plc (UK) ', 'Revance (US) ', 'NovaMedica (Russia)'

Healthcare providers are researching radiofrequency microneedling-based hyperhidrosis treatments and the outcomes seen in hyperhidrosis patients. Stakeholders are attempting to determine whether fractional microneedle radiofrequency treatment has long-term benefits, particularly for patients with primary axillary hyperhidrosis. These studies were evaluated using the hyperhidrosis disease severity scale (HDSS), which revealed that patients improved dramatically after treatment.

According to an article published in the International Hyperhidrosis Society in October 2020, excessive sweating of the armpits, hands, feet, head and face (craniofacial) and other relatively small body areas (such as under the breasts) can be treated with onabotulinumtoxinA. When used to treat excessive sweating under the arms, Botox has been shown to reduce sweating by 82-87%. The effects usually appear two to four days after treatment, with the full effects appearing within two weeks. Dryness typically lasts 4 to 12 months, but some studies have found that it can last up to 14 months.

North America is anticipated to dominate the global hyperhidrosis treatment market. Due to the high prevalence of various illnesses and existence of major market participants in the nation, the United States retains a sizable portion of the market. About 3% of Americans suffer from hyperhidrosis, which most frequently affects people between the ages of 20 and 60. Additionally, the growth of this market in the United States is anticipated to be fueled by rising research and development activities for hyperhidrosis treatment products in the country. This will result in higher acceptance of these products.
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients